Article Details

GT Biopharma (GTBP) Stock Jumped 17% In Premarket Market Trading. Why?

Retrieved on: 2021-03-09 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma (GTBP) Stock Jumped 17% In Premarket Market Trading. Why?. View article details on hiswai:

Excerpt

A prospective therapy for the treatment of prostate cancer generated positive preclinical results for GT Biopharma's ROR1 TriKE product candidate, as ...

Article found on: parktelegraph.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up